Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2016

Syncardia: The Irreplaceable Role of the Total Artificial Heart

Presenter: Daniel Burkhoff, Yoshifumi Naka, Keyur Bharat Shah

November 01, 2016

Presentation TCT 2016

Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care

Presenter: Daniel Burkhoff, Yoshifumi Naka, Nir Uriel

November 01, 2016

Presentation TCT 2016

Jarvik: Has the Problem of Driveline Infections Been Solved?

Presenter: Daniel Burkhoff, Yoshifumi Naka

November 01, 2016

Presentation TCT 2016

Heart Mate III: Has the Problem of Thrombus Been Solved?

Presenter: Daniel Burkhoff, Yoshifumi Naka, James W Long

November 01, 2016

Presentation TCT 2016

HVAD & MVAD

Presenter: Daniel Burkhoff, Yoshifumi Naka, Palak Shah

November 01, 2016

Presentation TCT 2016

State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients

Presenter: Daniel Burkhoff, Yoshifumi Naka, Nir Uriel

November 01, 2016

Presentation TCT 2016

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

Presenter: Daniel Burkhoff, Yoshifumi Naka, James W Long

November 01, 2016

News Daily News

研究称缺血性心肌病的患者可以受益于心肌卸负荷

Michael O'Riordan

October 17, 2016

News Daily News

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Michael O'Riordan

October 17, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

Presentation CATCH-UP 2015

Right Heart Failure After LVAD

Presenter: Maryjane Farr

April 25, 2015

Presentation CATCH-UP 2015

LVAD State of the Field

Presenter: Paolo C. Colombo

April 24, 2015

Presentation TCT 2014

LVADs for Chronic Heart Failure - Lessons Learned from HMII, HVAD, Jarvik, and Others

Presenter: John C Criscione, Elmir Omerovic, Bartley P. Griffith

September 16, 2014

Presentation TCT 2014

Advanced Heart Failure Therapies in 2014: LVAD or Transplant?

Presenter: Finn Gustafsson

September 16, 2014

Presentation TCT 2013

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Presenter: Keith Aaronson

October 28, 2013

Advertisement

Syncardia: The Irreplaceable Role of the Total Artificial Heart

Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care

Jarvik: Has the Problem of Driveline Infections Been Solved?

Heart Mate III: Has the Problem of Thrombus Been Solved?

HVAD & MVAD

State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

研究称缺血性心肌病的患者可以受益于心肌卸负荷

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Right Heart Failure After LVAD

LVAD State of the Field

LVADs for Chronic Heart Failure - Lessons Learned from HMII, HVAD, Jarvik, and Others

Advanced Heart Failure Therapies in 2014: LVAD or Transplant?

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content